
The Scotts Miracle-Gro Company Income Statement 2025-2007 | SMG
Brief overview of financial performance at The Scotts Miracle-Gro Company
The overview follows changes across a five-year period. Revenue at The Scotts Miracle-Gro Company moved from 4.1 billion dollars in 2020 to 3.4 billion dollars in 2025. The five-year change reached −17.4%, while CAGR stood at −3.7%. Revenue ended the period on a sustained downward trend.
Gross profit changed from 1.3 billion dollars to 1 billion dollars (−22.5%). Direct costs broadly followed the top-line trend. Gross profit as a share of revenue changed from 32.6% to 30.6%. The business retained less gross profit from each unit of revenue.
EBITDA was $680 million at the beginning and $421 million at the end of the period (−38%). EBITDA underperformed the top-line trend. The EBITDA share of revenue changed from 16.5% to 12.3%. Cost pressure reduced operating profitability.
Net profit was $387 million at the start and $145 million at the end. The business generated less net income by the end of the period.
Market value was 10.8 billion dollars at the start and 3.2 billion dollars at the end. The decline in value indicates softer investor confidence.
Overall conclusion
The financial trajectory is weak and requires a cautious interpretation. The main areas of concern are weaker gross profitability, a weaker market valuation and weaker operating efficiency. Investors should continue to monitor margins, costs, and earnings quality.
Annual Income Statement The Scotts Miracle-Gro Company
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
3.2 B | 4.4 B | 3.14 B | 2.98 B | 8.89 B | 10.8 B | 5.47 B | 3.82 B | 5.87 B | 5.39 B | 4.04 B | 3.61 B | 3.61 B | 2.56 B | 3.23 B | 2.92 B | 2.23 B | - | - |
Shares |
57.6 M | 56.8 M | 56 M | 55.5 M | 55.7 M | 55.7 M | 55.5 M | 56.2 M | 59.4 M | 61.1 M | 61.1 M | 61.6 M | 61.7 M | 61 M | 64.7 M | 66.3 M | 65 M | - | - |
Historical Prices |
55.5 | 77.5 | 56.1 | 53.6 | 160 | 195 | 99.4 | 56.1 | 95.2 | 82.7 | 54.4 | 51 | 47.8 | 32.8 | 33.9 | 44.1 | 34.3 | 27.6 | 45.6 |
Net Income |
145 M | -34.9 M | -380 M | -438 M | 512 M | 387 M | 461 M | 63.7 M | 218 M | 315 M | 160 M | 166 M | 161 M | 106 M | 168 M | 204 M | 153 M | -10.9 M | - |
Revenue |
3.41 B | 3.55 B | 3.55 B | 3.92 B | 4.92 B | 4.13 B | 3.16 B | 2.66 B | 2.64 B | 2.84 B | 3.02 B | 2.84 B | 2.82 B | 2.83 B | 2.84 B | - | - | - | - |
Cost of Revenue |
2.35 B | 2.62 B | 2.71 B | 2.89 B | 3.43 B | 2.77 B | 2.13 B | 1.78 B | 1.67 B | 1.6 B | 1.56 B | 1.69 B | 1.79 B | 1.81 B | 1.77 B | 1.78 B | 1.76 B | 1.88 B | - |
Gross Profit |
1.04 B | 850 M | 657 M | 873 M | 1.47 B | 1.35 B | 1.02 B | 865 M | 973 M | 995 M | 1.06 B | 1.03 B | 982 M | 961 M | 1 B | 1.09 B | 978 M | 912 M | - |
Operating Income |
359 M | 209 M | -174 M | -434 M | 723 M | 585 M | 410 M | 199 M | 433 M | 448 M | 254 M | 284 M | 310 M | 241 M | 275 M | 374 M | 260 M | 140 M | - |
Interest Expense |
129 M | 159 M | 178 M | 118 M | 78.9 M | 79.6 M | 102 M | 86.4 M | 76.1 M | 62.9 M | 48.8 M | 47.3 M | 59.2 M | 61.8 M | 51 M | 43.2 M | 52.4 M | 82.2 M | - |
EBITDA |
421 M | 289 M | -81.9 M | -329 M | 817 M | 680 M | 450 M | 361 M | 451 M | 425 M | 436 M | 371 M | 387 M | 312 M | 365 M | 423 M | 308 M | 194 M | - |
Operating Expenses |
- | - | - | - | - | - | 603 M | 532 M | 544 M | 586 M | 698 M | 670 M | 661 M | 711 M | 700 M | - | - | - | - |
General and Administrative Expenses |
603 M | 559 M | 551 M | 613 M | 744 M | 758 M | 408 M | 364 M | 366 M | 403 M | 698 M | 478 M | 661 M | 706 M | 700 M | 693 M | 699 M | 657 M | - |
All numbers in USD currency
Quarterly Income Statement The Scotts Miracle-Gro Company
| 2026-Q3 | 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | 2010-Q3 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
58.2 M | 58.1 M | 57.9 M | 57.9 M | 57.8 M | 57.7 M | 57.6 M | 57.3 M | 57.1 M | 56.8 M | 56.8 M | 56.7 M | 56.5 M | 56.2 M | 56 M | 55.5 M | 55.5 M | 55.4 M | 55.5 M | 55.7 M | 55.7 M | 55.8 M | 55.7 M | - | 55.8 M | 55.6 M | 55.7 M | 55.8 M | 55.7 M | 55.5 M | 55.8 M | 55.3 M | 55.4 M | 55.4 M | 55.3 M | 57.6 M | 58.4 M | 59.2 M | 57.6 M | 60.1 M | 60.6 M | 61.1 M | 60.1 M | - | 61.4 M | 61.3 M | 60.9 M | 60.8 M | 61 M | 61.3 M | 60.8 M | 62.1 M | 62 M | 61.7 M | 62.1 M | 61.4 M | 61.2 M | 61.1 M | 61.4 M | 60.9 M | 62 M | 64.5 M | 60.9 M | 66.5 M |
Net Income |
112 M | 239 M | -125 M | -125 M | - | 149 M | 218 M | -69.5 M | - | 132 M | 158 M | -80.5 M | - | 43.7 M | 109 M | -64.7 M | -218 M | -444 M | 276 M | -50 M | 560 M | 226 M | 310 M | - | 3.9 M | 203 M | 252 M | -71.4 M | -57.9 M | 202 M | -71.4 M | -79.6 M | -147 M | 82.9 M | -79.6 M | -21.2 M | -33.4 M | 152 M | -21.2 M | -65.3 M | -26.6 M | 213 M | -65.3 M | - | -23.6 M | 133 M | 125 M | -74.6 M | -15.2 M | 122 M | -74.6 M | -65.7 M | -19.4 M | 148 M | -65.6 M | -67.7 M | -40.1 M | 93.3 M | -67.7 M | -73.9 M | -53.4 M | 112 M | -73.9 M | 176 M |
Revenue |
1.17 B | 1.46 B | 354 M | 354 M | - | 1.19 B | 1.42 B | 367 M | - | 1.2 B | 1.53 B | 410 M | - | 1.12 B | 1.53 B | 527 M | 3.43 B | 1.19 B | 1.68 B | 749 M | 4.19 B | 1.61 B | 1.83 B | - | 890 M | 1.49 B | 1.38 B | 366 M | 498 M | 1.17 B | 366 M | 298 M | 434 M | 995 M | 1.01 B | 222 M | 377 M | 973 M | 1.08 B | 207 M | 349 M | 887 M | 247 M | - | 375 M | 1.11 B | 1.07 B | 170 M | 454 M | 1.12 B | 216 M | 190 M | 434 M | 1.14 B | 196 M | 195 M | 401 M | 1.05 B | 206 M | 200 M | 403 M | 1.05 B | 211 M | - |
Cost of Revenue |
805 M | 849 M | 264 M | 264 M | - | 806 M | 866 M | 277 M | - | 851 M | 987 M | 354 M | - | 880 M | 1 B | 421 M | 2.42 B | 884 M | 1.08 B | 549 M | 2.82 B | 1.11 B | 1.16 B | - | 2.09 B | 954 M | 829 M | 311 M | 1.72 B | 747 M | 311 M | 261 M | 1.43 B | 636 M | 261 M | 188 M | 1.38 B | 590 M | 188 M | 171 M | 1.53 B | 636 M | 203 M | - | 1.53 B | 722 M | 647 M | 187 M | 1.5 B | 693 M | 187 M | 156 M | 1.49 B | 695 M | 162 M | 175 M | 1.57 B | 686 M | 175 M | 174 M | 1.5 B | 658 M | 186 M | 734 M |
Gross Profit |
366 M | 610 M | 88.7 M | 88.7 M | - | 378 M | 548 M | 88.5 M | - | 354 M | 464 M | 62.2 M | - | 206 M | 413 M | 95.7 M | 944 M | 237 M | 588 M | 191 M | 1.34 B | 495 M | 658 M | - | 216 M | 527 M | 550 M | 54.2 M | 89.5 M | 423 M | 54.2 M | 34.5 M | 73.7 M | 348 M | 34.5 M | 34 M | 88.1 M | 383 M | 34 M | 36.8 M | 92.2 M | 324 M | 44.2 M | - | 90.8 M | 386 M | 425 M | 6.6 M | 140 M | 423 M | 29.3 M | 33.9 M | 130 M | 440 M | 34.9 M | 30.6 M | 105 M | 369 M | 31.1 M | 25.6 M | 95.5 M | 400 M | 24.8 M | 505 M |
Operating Income |
170 M | 402 M | -21.8 M | -21.8 M | - | 215 M | 345 M | -45.8 M | - | 200 M | 272 M | -47.3 M | - | 77.3 M | 206 M | -41.8 M | -210 M | -562 M | 388 M | 34 M | 760 M | 302 M | 424 M | - | 576 M | 284 M | 354 M | -62.6 M | 464 M | 258 M | -62.6 M | -84.9 M | 346 M | 186 M | -84.9 M | -71.9 M | 460 M | 236 M | -71.9 M | -61.8 M | 488 M | 217 M | -70.9 M | - | 316 M | 191 M | 232 M | -106 M | 328 M | 201 M | -106 M | -89.7 M | 329 M | 249 M | -89.5 M | -91.9 M | 288 M | 170 M | -91.9 M | -99 M | 344 M | 192 M | -100 M | 290 M |
Interest Expense |
28 M | 31.3 M | 27.2 M | 27.2 M | - | 31.8 M | 36.6 M | 33.9 M | - | 38.8 M | 44.1 M | 42.8 M | - | 47.1 M | 48.3 M | 42.7 M | 83.1 M | 31 M | 28.3 M | 16.1 M | 57.3 M | 21.9 M | 19.3 M | - | 63 M | 20.3 M | 22.7 M | 20 M | 80 M | 25.9 M | 20 M | 25.2 M | 63.6 M | 23.2 M | 25.2 M | 17.8 M | 58.5 M | 21.8 M | 17.8 M | 15.3 M | 52.3 M | 16.9 M | 15.6 M | - | 39 M | 14.3 M | 15 M | 9.7 M | 38.7 M | 12.8 M | 9.7 M | 13.9 M | 47.9 M | 16.8 M | 13.9 M | 13.2 M | 49.8 M | 16.6 M | 13.2 M | 15.3 M | 37.3 M | 14 M | 15.3 M | 11.9 M |
EBITDA |
217 M | 433 M | -6.2 M | -6.2 M | - | - | - | -30 M | - | - | - | -31.2 M | - | - | - | -24.3 M | -160 M | -562 M | 388 M | 49.7 M | 807 M | 333 M | 424 M | - | 621 M | 315 M | 354 M | -47.8 M | 505 M | 286 M | -47.8 M | -70.9 M | 385 M | 211 M | -70.9 M | -59.2 M | 501 M | 264 M | -59.2 M | -47.8 M | 529 M | 244 M | -56.9 M | - | 354 M | 216 M | 232 M | -93.5 M | 366 M | 227 M | -93.5 M | -76.7 M | 370 M | 276 M | -76.5 M | -78.3 M | 328 M | 196 M | -78.3 M | -86.1 M | 381 M | 217 M | -87.3 M | 327 M |
General and Administrative Expenses |
146 M | 199 M | 106 M | 106 M | - | 153 M | 188 M | 114 M | - | 148 M | 179 M | 115 M | - | 128 M | 186 M | 128 M | 495 M | 136 M | 205 M | 157 M | 582 M | 194 M | 232 M | - | 553 M | 238 M | 196 M | 120 M | 462 M | 166 M | 120 M | 116 M | 419 M | 144 M | 116 M | 108 M | 436 M | 153 M | 108 M | 104 M | 466 M | 152 M | 119 M | - | 450 M | 155 M | 189 M | 127 M | 526 M | 189 M | 127 M | 124 M | 520 M | 189 M | 125 M | 124 M | 557 M | 198 M | 124 M | 122 M | 552 M | 192 M | 123 M | 214 M |
All numbers in USD currency
The income statement is one of the three key financial reports of a company The Scotts Miracle-Gro Company (alongside the balance sheet and the cash flow statement). It shows how the company makes money and what its expenses are:
- How much revenue the company earned
- How much it spent on production, personnel, marketing, taxes, etc.
- What profit remained in the end
Analyzing the income statement helps an investor understand whether the business generates stable and growing profits, how effectively the company controls its expenses, and whether it is capable of generating income in the future. Additionally, this analysis shows how the company copes with crises and economic cycles, and allows assessing the potential for stock price growth and dividend payments.
Features- The income statement may include both recurring and one-time items (for example, profit from the sale of assets). It is necessary to separate core metrics from one-off events for accurate analysis.
- Companies often publish interim reports (e.g., quarterly), which allows for more timely tracking of trends.
- A combined analysis of the income statement with the balance sheet and cash flow statement provides a comprehensive view of the company’s financial health.
Reports on the profits and losses of other stocks in the Agricultural inputs industry
| Issuer | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|
|
China Green Agriculture
CGA
|
- | 0.51 % | $ 27.6 M | ||
|
Акрон
AKRN
|
- | - | - | ||
|
American Vanguard Corporation
AVD
|
$ 2.33 | 0.87 % | $ 66.2 M | ||
|
CF Industries Holdings
CF
|
$ 133.35 | 2.71 % | $ 21.6 B | ||
|
FMC Corporation
FMC
|
$ 12.97 | 0.23 % | $ 1.62 B | ||
|
The Mosaic Company
MOS
|
$ 25.85 | 1.39 % | $ 8.2 B | ||
|
Marrone Bio Innovations
MBII
|
- | -5.9 % | $ 180 M | ||
|
ICL Group Ltd
ICL
|
$ 5.87 | 0.69 % | $ 7.58 B | ||
|
Yield10 Bioscience
YTEN
|
- | 15.32 % | $ 46.6 M | ||
|
ФосАгро
PHOR
|
- | - | - | ||
|
Corteva
CTVA
|
$ 87.86 | 2.65 % | $ 59.7 B | ||
|
Origin Agritech Limited
SEED
|
$ 1.01 | 0.25 % | $ 7.57 M | ||
|
Arcadia Biosciences
RKDA
|
$ 0.47 | 0.23 % | $ 643 K | ||
|
CVR Partners, LP
UAN
|
$ 130.8 | 2.83 % | $ 1.38 B | ||
|
Bioceres Crop Solutions Corp.
BIOX
|
$ 0.43 | 3.51 % | $ 27.2 M | ||
|
Intrepid Potash
IPI
|
$ 40.51 | 0.42 % | $ 527 M | ||
|
Nutrien Ltd.
NTR
|
$ 79.47 | 0.55 % | $ 38.6 B |